Surface Oncology, Inc.
SURF · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $52,800 | $42,367 | $49,661 | $61,417 |
| - Cash | $14,842 | $28,982 | $50,910 | $65,096 |
| + Debt | $9,488 | $55,457 | $56,037 | $56,567 |
| Enterprise Value | $47,446 | $68,842 | $54,788 | $52,888 |
| Revenue | $0 | $0 | $30,000 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $30,000 | $0 |
| % Margin | – | – | 100% | – |
| EBITDA | -$23,095 | -$18,491 | -$29,072 | -$22,065 |
| % Margin | – | – | -96.9% | – |
| Net Income | -$28,192 | -$20,751 | -$21,482 | -$23,582 |
| % Margin | – | – | -71.6% | – |
| EPS Diluted | -0.46 | -0.34 | -0.35 | -0.4 |
| % Growth | -35.3% | 2.9% | 12.5% | – |
| Operating Cash Flow | -$19,561 | -$23,439 | -$21,754 | -$18,827 |
| Capital Expenditures | $17 | -$17 | -$292 | -$59 |
| Free Cash Flow | -$19,544 | -$23,456 | -$22,046 | -$18,886 |